Mizuho Markets Cayman’s DexCom DXCM Stock Holding History

Mizuho Markets Cayman’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-74,000	Closed	-$6.46M	–	95
2025 Q2	$6.46M	Buy	+74,000	New	+$5.8M	0.46%	29

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Mizuho Markets Cayman's DXCM Position: Q3 2025 in Review

Mizuho Markets Cayman sold out of DexCom (DXCM) in Q3 2025, closing a stake of 74,000 shares — an estimated $6.46M sold.

Mizuho Markets Cayman first reported a position in DXCM in Q2 2025 and held it in 1 quarter. The position peaked at $6.46M in Q2 2025. 911 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

Mizuho Markets Cayman reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
Mizuho Markets Cayman sold 74,000 DexCom shares in Q3 2025, an estimated $6.46M.
Mizuho Markets Cayman first reported a position in DexCom in Q2 2025 and held it in 1 quarter.
Mizuho Markets Cayman's DexCom position peaked at $6.46M in Q2 2025.
911 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Mizuho Markets Cayman's 13F filing for Q3 2025, filed 14 Nov 2025.